Regulatory approval for the cannabis extract known as Sativex was expected in the UK by the end of 2003. I thought the biggest story in the cannabis world of 2003 was the denial of Sativex in the UK. It was denied by more stonewalling through all of 2004 and even today as Canada beat the acceptance of Sativex by its home country.
So today, Canada lets down the gate and the stonewall defense is no longer workable by the prohibitionists. The warning label is of particular interest as cannabis is a model of safety in the pharmacological world. It will be nice to see people actually take the Sativex on television and tell of the transformation. With MS this can be dramatic as a person can go from wheelchair to walking with the use of cannabis in just a few minutes.
Following are the first four paragraphs of the announcement by the Globe and Mail newspaper out of Toronto-
http://tinyurl.com/8bhdfCanada is the first country in the world to approve a cannabis spray that relieves pain in people with multiple sclerosis, Health Canada said Tuesday.
The announcement sent shares of the U.K. maker of the drug, GW Pharmaceuticals Plc, up as much as 14 per cent in London. Bayer AG will market the drug in Canada.
Sativex, which is administered through a spray in the mouth, relieves pain in patients that suffer from MS, the government agency said. It's expected to hit the shelves by late spring.
“Effective pain control and management are extremely important in a disease like MS,” said Dr. Allan Gordon, neurologist and director of the Wasser Pain Management Centre at Mount Sinai Hospital in Toronto, in a statement. “The approval of Sativex in Canada reflects the urgent need for additional treatment options in the field of neuropathic pain in MS.”